CoChat
Sign Up
Cited by 244

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Magnetic Resonance Imaging and Iron-oxide Nanoparticles in the era of Personalized Medicine

Rahman, Mahbuba·2023·Nanotheranostics
DOI 10.7150/ntno.86467PMC PMC10464520
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.7150/ntno.86467

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 MRI scanner (A) and A graphical representation of the acquisition of the MRI signal (B).
Figure 1 MRI scanner (A) and A graphical representation of the acquisition of the MRI signal (B).CC BY · PubMed Central
Figure 2 Magnetic behavior of IONPs (A), Route of administration (B) and Biological distribution of different sizes of IONPs (C).
Figure 2 Magnetic behavior of IONPs (A), Route of administration (B) and Biological distribution of different sizes of IONPs (C).CC BY · PubMed Central
Figure 3 Multifunctional SPION (A), Different biocompatible coatings (B), Inorganic nanoparticles (C) and, SPIONs used is multimodal imaging (D)
Figure 3 Multifunctional SPION (A), Different biocompatible coatings (B), Inorganic nanoparticles (C) and, SPIONs used is multimodal imaging (D)CC BY · PubMed Central
Figure 4 Application of SPION as nanotheranostics: (i) passive targeting, (ii) active targeting, and (iii) magnetic targeting
Figure 4 Application of SPION as nanotheranostics: (i) passive targeting, (ii) active targeting, and (iii) magnetic targetingCC BY · PubMed Central
Figure 5 Factors associated with MRI-nanotheranostics for application in Personalized Medicine
Figure 5 Factors associated with MRI-nanotheranostics for application in Personalized MedicineCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 67

  1. [1]Goetz LH Schork NJ Personalized medicine: motivation, challenges, and progress Fertil Steril [Internet] 2018 109 6 952 63 Available from: https://doi.org/10.1016/j.fertnstert.2018.05.006 29935653 PMC6366451 · DOI · Paper page
  2. [2]Atutornu J Hayre CM Personalised Medicine and Medical Imaging: Opportunities and Challenges for Contemporary Health Care J Med Imaging Radiat Sci [Internet] 2018 49 4 352 9 Available from: https://doi.org/10.1016/j.jmir.2018.07.002 30514550 · DOI
  3. [3]Beger RD Schmidt MA Kaddurah-Daouk R Current concepts in pharmacometabolomics, biomarker discovery, and precision medicine Metabolites 2020 10(4) PMC7241083 32230776
  4. [4]Ingle AP Golińska P Yadav A Razzaghi-Abyaneh M Patel M Patel R Nanotechnology: A New Era in the Revolution of Drug Delivery, Diagnosis, and Treatment of Diseases Nanobiotechnology Diagnosis, Drug Deliv Treat [Internet] 2020 1 24 Available from: https://scholar.google.com/citations?view_op=view_citation&hl=en&user=8rykdvYAAAAJ&cstart=500&pagesize=100&citation_for_view=8rykdvYAAAAJ:fGk8ZXjgAbkC
  5. [5]Anselmo AC Mitragotri S Nanoparticles in the clinic: An update Bioeng Transl Med 2019 4 3 1 16 PMC6764803 31572799
  6. [7]Vizirianakis IS Fatouros DG Personalized nanomedicine: paving the way to the practical clinical utility of genomics and nanotechnology advancements Adv Drug Deliv Rev 2012 64 13 1359 62 22983333
  7. [8]Blau R Krivitsky A Epshtein Y Satchi-Fainaro R Are nanotheranostics and nanodiagnostics-guided drug delivery stepping stones towards precision medicine? Drug Resist Updat [Internet] 2016 27 39 58 Available from: http://dx.doi.org/10.1016/j.drup.2016.06.003 27449597 · DOI
  8. [9]Flores-Rojas GG López-Saucedo F Vera-Graziano R Mendizabal E Bucio E Magnetic Nanoparticles for Medical Applications: Updated Review Macromol 2022 2 3 374 90
  9. [10]Tan M Lu Z-R Integrin Targeted MR Imaging Theranostics 2012 1 83 101 PMC3086609 21547154
  10. [11]Hoerr V Faber C Magnetic resonance imaging characterization of microbial infections J Pharm Biomed Anal [Internet] 2014 93 136 46 Available from: http://dx.doi.org/10.1016/j.jpba.2013.10.034 24257444 · DOI
  11. [13]Eftekhari A Arjmand A Asheghvatan A Švajdlenková H Šauša O Abiyev H The Potential Application of Magnetic Nanoparticles for Liver Fibrosis Theranostics Front Chem 2021 9 May 1 15 PMC8161198 34055744
  12. [14]James ML Gambhir SS A molecular imaging primer: Modalities, imaging agents, and applications Physiol Rev 2012 92 2 897 965 22535898
  13. [16]Dadfar SM Roemhild K Drude NI Von S Iron Oxide Nanoparticles: Diagnostic, Therapeutic and Theranostic Applications 2020;302-25 PMC7115878 30639256
  14. [17]Ryu JH Lee S Son S Kim SH Leary JF Choi K Theranostic nanoparticles for future personalized medicine J Control Release [Internet] 2014 190 477 84 Available from: http://dx.doi.org/10.1016/j.jconrel.2014.04.027 24780269 · DOI
  15. [18]Neri E Regge D Imaging biobanks in oncology: European perspective Futur Oncol 2017 13 5 433 41 27788586
  16. [19]Dregely I Prezzi D Kelly-Morland C Roccia E Neji R Goh V Imaging biomarkers in oncology: Basics and application to MRI J Magn Reson Imaging 2018 48 1 13 26 29969192 PMC6587121
  17. [21]Murar M Albertazzi L Pujals S Advanced Optical Imaging-Guided Nanotheranostics toward Personalized Cancer Drug Delivery Nanomaterials 2022 12 3 1 17 PMC8838478 35159744
  18. [22]Tachibana N [Historical overview of REM Brain Nerve / Shinkei Kenkyu no Shinpo 2009 61 5 558 68 19514516
  19. [23]Serai SD Ho ML Artunduaga M Chan SS Chavhan GB Components of a magnetic resonance imaging system and their relationship to safety and image quality Pediatr Radiol 2021 51 5 716 23 33871725
  20. [24]Nelson N Port J Pandey M Use of Superparamagnetic Iron Oxide Nanoparticles (SPIONs) via Multiple Imaging Modalities and Modifications to Reduce Cytotoxicity: An Educational Review J Nanotheranostics 2020 1 1 105 35
  21. [26]Rosa L Blackledge J Boretti A Nano-magnetic resonance imaging (Nano-MRI) gives personalized medicine a new perspective Biomedicines 2017 5 1 1 13 28536350 PMC5423496
  22. [27]Hengerer A Grimm J Molecular magnetic resonance imaging Biomed Imaging Interv J 2006 2(2) PMC3097616 21614236
  23. [28]Smith L Kuncic Z Byrne HL Waddington D Nanoparticles for MRI-guided radiation therapy: a review Cancer Nanotechnol [Internet] 2022 13 1 1 28 Available from: https://doi.org/10.1186/s12645-022-00145-8 · DOI
  24. [29]Martins PM Lima AC Ribeiro S Lanceros-Mendez S Martins P Magnetic Nanoparticles for Biomedical Applications: From the Soul of the Earth to the Deep History of Ourselves ACS Appl Bio Mater 2021 4 8 5839 70 35006927
  25. [30]Wahajuddin Arora S Superparamagnetic iron oxide nanoparticles: Magnetic nanoplatforms as drug carriers Int J Nanomedicine 2012 7 3445 71 22848170 PMC3405876
  26. [31]Laurent S Saei AA Behzadi S Panahifar A Mahmoudi M Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: Opportunities and challenges Expert Opin Drug Deliv 2014 11 9 1449 70 24870351
  27. [32]Cortajarena AL Ortega D Ocampo SM Gonzalez-García A Couleaud P Miranda R Engineering Iron Oxide Nanoparticles for Clinical Settings Nanobiomedicine 2014 1 PMC6029241 30023013
  28. [33]Mitchell MJ Billingsley MM Haley RM Wechsler ME Peppas NA Langer R Engineering precision nanoparticles for drug delivery Nat Rev Drug Discov [Internet] 2021 20 2 101 24 Available from: http://dx.doi.org/10.1038/s41573-020-0090-8 33277608 PMC7717100 · DOI · Paper page
  29. [34]Mahmoudi M Sahraian MA Shokrgozar MA Laurent S Superparamagnetic iron oxide nanoparticles: Promises for diagnosis and treatment of multiple sclerosis ACS Chem Neurosci 2011 2 3 118 40 22778862 PMC3369738
  30. [35]Zhao S Yu X Qian Y Chen W Shen J Multifunctional magnetic iron oxide nanoparticles: An advanced platform for cancer theranostics Theranostics 2020 10 14 6278 309 32483453 PMC7255022
  31. [36]Al-Jamal WT Kostarelos K Liposome-nanoparticle hybrids for multimodal diagnostic and therapeutic applications Nanomedicine 2007 2 1 85 98 17716195
  32. [37]Fattahi H Laurent S Liu F Arsalani N Elst L Vander Muller RN Magnetoliposomes as multimodal contrast agents for molecular imaging and cancer nanotheragnostics Nanomedicine 2011 6 3 529 44 21542690
  33. [38]Ivanova N Gugleva V Dobreva M Pehlivanov I Stefanov S Andonova V Perspective Chapter: Magnetoliposomes - A Recent Development as Recent Advances in the Field of Controlled Release Drug Delivery In: Intech 2016 p. 13
  34. [39]Mitchell N Kalber TL Cooper MS Sunassee K Chalker SL Shaw KP Incorporation of paramagnetic, fluorescent and PET/SPECT contrast agents into liposomes for multimodal imaging Biomaterials [Internet] 2013 34 4 1179 92 Available from: http://dx.doi.org/10.1016/j.biomaterials.2012.09.070 23131536 PMC3520009 · DOI
  35. [40]Ren L Chen S Li H Zhang Z Ye C Liu M MRI-visible liposome nanovehicles for potential tumor-targeted delivery of multimodal therapies Nanoscale 2015 7 30 12843 50 26022345
  36. [41]McAteer MA Choudhury RP Applications of nanotechnology in molecular imaging of the brain [Internet] First edit. Vol. 180, Progress in Brain Research. Elsevier 2009 72 96 p. Available from: http://dx.doi.org/10.1016/S0079-6123(08)80004-0 20302829 · DOI
  37. [42]Dulińska-Litewka J Łazarczyk A Hałubiec P Szafrański O Karnas K Karewicz A Superparamagnetic iron oxide nanoparticles-current and prospective medical applications Materials (Basel) 2019 12(4) PMC6416629 30791358
  38. [43]Hobson NJ Weng X Siow B Veiga C Ashford M Thanh NTK Clustering superparamagnetic iron oxide nanoparticles produces organ-Targeted high-contrast magnetic resonance images Nanomedicine 2019 14 9 1135 52 31050589
  39. [44]Ferreira M Sousa J Pais A Vitorino C The role of magnetic nanoparticles in cancer nanotheranostics Materials (Basel) 2020 13 2 1 25 PMC7014348 31936128
  40. [45]Plassat V Martina MS Barratt G Ménager C Lesieur S Sterically stabilized superparamagnetic liposomes for MR imaging and cancer therapy: Pharmacokinetics and biodistribution Int J Pharm 2007 344 1-2 118 27 17583452
  41. [46]Martina MS Wilhelm C Lesieur S The effect of magnetic targeting on the uptake of magnetic-fluid-loaded liposomes by human prostatic adenocarcinoma cells Biomaterials 2008 29 30 4137 45 18667235
  42. [47]Kostevšek N Cheung CCL Serša I Kreft ME Monaco I Franchini MC Magneto-liposomes as MRI contrast agents: A systematic study of different liposomal formulations Nanomaterials 2020 10(5) PMC7279489 32384645
  43. [49]Ali A Zafar H Zia M Haq I ul Phull AR Ali JS Synthesis, characterization, applications, and challenges of iron oxide nanoparticles Nanotechnol Sci Appl 2016 9 49 67 27578966 PMC4998023
  44. [50]Wang Y-XJ Current status of superparamagnetic iron oxide contrast agents for liver magnetic resonance imaging World J Gastroenterol 2015 21 47 13400 2 26715826 PMC4679775
  45. [51]Wáng YXJ Idée JM A comprehensive literatures update of clinical researches of superparamagnetic resonance iron oxide nanoparticles for magnetic resonance imaging Quant Imaging Med Surg 2017 7 1 88 122 28275562 PMC5337187
  46. [52]Li Z Bai R Yi J Zhou H Xian J Chen C Designing Smart Iron Oxide Nanoparticles for MR Imaging of Tumors Chem Biomed Imaging. 2023 PMC10369497 37501794
  47. [54]Siegel RL Miller KD Jemal A Cancer statistics, 2020 CA Cancer J Clin 2020 70 1 7 30 31912902
  48. [55]Ladju RB Ulhaq ZS Soraya GV Nanotheranostics: A powerful next-generation solution to tackle hepatocellular carcinoma World J Gastroenterol 2022 28 2 176 87 35110943 PMC8776531
  49. [56]Bhushan A Gonsalves A Menon JU Current state of breast cancer diagnosis, treatment, and theranostics Pharmaceutics 2021 13 5 1 24 PMC8156889 34069059
  50. [57]Lee D Sohn J Kirichenko A Quantifying Liver Heterogeneity via R2*-MRI with Super-Paramagnetic Iron Oxide Nanoparticles (SPION) to Characterize Liver Function and Tumor Cancers (Basel) 2022 14 21 5269 36358689 PMC9653969
  51. [58]Alexander Neuwelt Navneet Sidhu Chien-AN A Hu, Gary Mlady, Steven C. Eberhardt and LOS. Iron-Based Superparamagnetic Nanoparticle Contrast Agetns for MRI of Infection and Inflammation Physiol Behav 2018 176 1 139 48 PMC4395032 25714316
  52. [59]Sechi E Flanagan EP Antibody-Mediated Autoimmune Diseases of the CNS: Challenges and Approaches to Diagnosis and Management Front Neurol 2021 12 July 1 18 PMC8292678 34305787
  53. [60]Anna Sargsyan S Thurman JM Molecular imaging of autoimmune diseases and inflammation Mol Imaging 2012 11 3 251 64 22554489
  54. [63]Saleh A Schroeter M Ringelstein A Hartung HP Siebler M Mödder U Iron oxide particle-enhanced MRI suggests variability of brain inflammation at early stages after ischemic stroke Stroke 2007 38 10 2733 7 17717318
  55. [64]Papafilippou L Claxton A Dark P Kostarelos K Hadjidemetriou M Nanotools for Sepsis Diagnosis and Treatment Adv Healthc Mater 2021 10 1 1 25 PMC11469323 33236524
  56. [65]Signore A Glaudemans AWJM Galli F Rouzet F Imaging infection and inflammation Biomed Res Int 2015 2015 10 3 PMC4387941 25879030
  57. [66]Gobbo OL Sjaastad K Radomski MW Volkov Y Prina-Mello A Magnetic nanoparticles in cancer theranostics Theranostics 2015 5 11 1249 63 26379790 PMC4568452
  58. [67]Park T Amatya R Min KA Shin MC Liposomal Iron Oxide Nanoparticles Loaded with Doxorubicin for Combined Chemo-Photothermal Cancer Therapy Pharmaceutics 2023 15(1) PMC9860715 36678921
  59. [68]Anani T Rahmati S Sultana N David AE MRI-traceable theranostic nanoparticles for targeted cancer treatment Theranostics 2020 11 2 579 601 PMC7738852 33391494
  60. [70]Hayashi K Nakamura M Sakamoto W Yogo T Miki H Ozaki S Superparamagnetic nanoparticle clusters for cancer theranostics combining magnetic resonance imaging and hyperthermia treatment Theranostics 2013 3 6 366 76 23781284 PMC3677408
  61. [71]Thomas RG Moon MJ Lee H Sasikala ARK Kim CS Park IK Hyaluronic acid conjugated superparamagnetic iron oxide nanoparticle for cancer diagnosis and hyperthermia therapy Carbohydr Polym [Internet] 2015 131 439 46 Available from: http://dx.doi.org/10.1016/j.carbpol.2015.06.010 26256205 · DOI
  62. [72]Silva CO Pinho JO Lopes JM Almeida AJ Gaspar MM Reis C Current trends in cancer nanotheranostics: Metallic, polymeric, and lipid-based systems Pharmaceutics 2019 11(1) PMC6359642 30625999
  63. [73]Prijic S Sersa G Magnetic nanoparticles as targeted delivery systems in oncology Radiol Oncol 2011 45 1 1 16 22933928 PMC3423716
  64. [74]Sritama Nath and Pinku Mukherjee Muc1: a multifaceted oncoprotein with a key role in cancer progression Sritama Physiol Behav 2017 176 12 139 48 24667139 PMC5500204
  65. [75]Azhdarzadeh M Atyabi F Saei AA Varnamkhasti BS Omidi Y Fateh M Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer Colloids Surfaces B Biointerfaces [Internet] 2016 143 224 32 Available from: http://dx.doi.org/10.1016/j.colsurfb.2016.02.058 27015647 · DOI
  66. [76]Liu Y Yang F Yuan C Li M Wang T Chen B Magnetic Nanoliposomes as in Situ Microbubble Bombers for Multimodality Image-Guided Cancer Theranostics ACS Nano 2017 11 2 1509 19 28045496
  67. [78]Laura H Goetz, M.D. and Nicholas J. Schork P. Personalized Medicine: Motivation, Challenges and Progress Physiol Behav 2019 176 3 139 48 PMC6366451 29935653

Cited by

Sorted by citations

Metadata

Authors
Rahman, M.
Venue
Nanotheranostics
Publisher
Ivyspring International Publisher
Published
2023
Volume
7
Issue
4
Pages
424-449
ISSN
2206-7418
DOI
10.7150/ntno.86467
PMC
PMC10464520
Cited by
244
References
3
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review